PURA - Puration Inc Confirms CEO Audio Interview Scheduled For Release This Week

Dallas, TX -- October 15, 2018 -- Investorshub NewsWire -- Puration, Inc. (USOTC: PURA) today confirmed that an audio interview of CEO Brian Shibley is schedule for release this week. The interview was referenced this past Thursday, October 11^th, 2018 when the company published an online management presentation to provide more detail on its recent corporate restructuring to concentrate resources on its rapidly expanding cannabis infused beverage business. The presentation can be viewed in its entirety by following the link below:

Puration Inc Garners Interest From $330 Billion Beverage Industry Brand Name Players

In addition to indicating a CEO interview would be forthcoming this week, the presentation also includes details on the company’s recently announced spinoff of its cannabis cultivation business and the pending dividend distribution of spinoff stock. It also includes details on the company’s current two cannabis infused beverages and the recently announced letter of intent to acquire a company with a third cannabis sector beverage.

With Corona Beer parent Constellation Brands and Molson Coors Brewing Co. having already moved into the cannabis sector and Coca-Cola “eyeing” the sector, Puration CEO, Brian Shibley answers questions in the soon to be released interview about Puration’s experience and recent encounters with recognized beverage industry brand name players. The interview has already taken place and the recording of the interview is expected to be released imminently.

Goldman Small Cap Puration Research Report: Speculative-Buy and Target $0.25 PPS

Goldman Small Cap Research issued a research report on Puration, Inc. published October 10, 2018. The report includes a 'speculative-buy' rating with a target price-per-share of $0.25. The report provides an in-depth overview and analysis of Puration's successes, approach, new initiatives, and upcoming milestones. To view the report, along with disclosures and disclaimers, visit http://www.GoldmanResearch.com or https://www.purationinc.com/goldman-research/.

Learn more about Puration at www.purationinc.com
Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350